A detailed history of Long Run Wealth Advisors, LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Long Run Wealth Advisors, LLC holds 1,655 shares of ABBV stock, worth $321,401. This represents 0.07% of its overall portfolio holdings.

Number of Shares
1,655
Previous 1,977 16.29%
Holding current value
$321,401
Previous $360,000 21.39%
% of portfolio
0.07%
Previous 0.1%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 19, 2024

SELL
$154.79 - $180.76 $49,842 - $58,204
-322 Reduced 16.29%
1,655 $283,000
Q1 2024

Apr 24, 2024

SELL
$159.82 - $182.1 $31,964 - $36,420
-200 Reduced 9.19%
1,977 $360,000
Q4 2023

Jan 10, 2024

SELL
$137.6 - $154.97 $13,209 - $14,877
-96 Reduced 4.22%
2,177 $337,000
Q3 2023

Oct 10, 2023

BUY
$133.59 - $154.65 $1,469 - $1,701
11 Added 0.49%
2,273 $338,000
Q4 2021

Jan 21, 2022

BUY
$107.43 - $135.93 $243,006 - $307,473
2,262 New
2,262 $306,000

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $343B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Long Run Wealth Advisors, LLC Portfolio

Follow Long Run Wealth Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Long Run Wealth Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Long Run Wealth Advisors, LLC with notifications on news.